Companies that own Merus N.V.
BVF Partners LP
3,914,913
17.3%
1,495,470
5.65%
06/30/2018
Wellington Management Co. LLP
1,378,693
6.09%
-49,108
0.01%
06/30/2018
Aquilo Capital Management LLC
1,250,914
5.53%
1,250,914
22.34%
06/30/2018
Baker Bros. Advisors LP
1,160,014
5.13%
0
0.16%
06/30/2018
Tekla Capital Management LLC
414,115
1.83%
-65,035
0.28%
06/30/2018
T. Rowe Price Associates, Inc.
346,694
1.53%
-7,192
0%
06/30/2018
Platinum Investment Management Ltd.
102,219
0.45%
0
0.03%
06/30/2018
SV Health Managers LLP
75,060
0.33%
0
0.44%
06/30/2018
Iguana Healthcare Management LLC
75,000
0.33%
-25,000
1.05%
03/31/2018
Stanley-Laman Group Ltd.
57,396
0.25%
10,982
0.26%
06/30/2018
| Address |
Yalelaan 62
Utrecht Utrecht 3584 CH
Netherlands
|
|
Employees
|
- |
| Website |
http://www.merus.nl |
| Updated |
07/08/2019 |
| Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg on June 16, 2003 and is headquartered in Utrecht, Netherlands. |
